Contact

Parkinson's disease: a breakthrough thanks to gene therapy

Parkinson's disease: a breakthrough thanks to gene therapy

A Franco-British team (AP-HP, INSERM, UPEC, CEA / MIRCen, Oxford Biomedica, Cambridge University) conducted a Phase I-II gene therapy clinical trial in patients with an advanced form of Parkinson’s disease.

Click here to learn more